awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
s10637-012-9890-y
s10637-012-9890-y
https://scigraph.springernature.com/pub.10.1007/s10637-012-9890-y
A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors.
P2888
Q36660538-E849C409-B176-4282-9E91-3FD5C422904F
P2888
s10637-012-9890-y
https://scigraph.springernature.com/pub.10.1007/s10637-012-9890-y